| Nivolumab for recurrent squamous-cell carcinoma of the head and neck RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ... New England Journal of Medicine 375 (19), 1856-1867, 2016 | 4644 | 2016 |
| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2536 | 2014 |
| Head and neck cancer A Argiris, MV Karamouzis, D Raben, RL Ferris The Lancet 371 (9625), 1695-1709, 2008 | 2508 | 2008 |
| Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples YE Nikiforov, NP Ohori, SP Hodak, SE Carty, SO LeBeau, RL Ferris, L Yip, ... The Journal of Clinical Endocrinology & Metabolism 96 (11), 3390-3397, 2011 | 877 | 2011 |
| The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction NE Scharping, AV Menk, RS Moreci, RD Whetstone, RE Dadey, ... Immunity 45 (2), 374-388, 2016 | 818 | 2016 |
| Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by … RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ... Oral oncology 81, 45-51, 2018 | 749 | 2018 |
| Immunology and immunotherapy of head and neck cancer RL Ferris Journal of clinical oncology 33 (29), 3293, 2015 | 691 | 2015 |
| Lipid accumulation and dendritic cell dysfunction in cancer DL Herber, W Cao, Y Nefedova, SV Novitskiy, S Nagaraj, VA Tyurin, ... Nature medicine 16 (8), 880-886, 2010 | 656 | 2010 |
| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers VWY Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ... Cancer discovery 3 (7), 761-769, 2013 | 649 | 2013 |
| The changing therapeutic landscape of head and neck cancer JD Cramer, B Burtness, QT Le, RL Ferris Nature reviews Clinical oncology 16 (11), 669-683, 2019 | 566 | 2019 |
| The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ... Journal for immunotherapy of cancer 7, 1-31, 2019 | 549 | 2019 |
| Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay YE Nikiforov, SE Carty, SI Chiosea, C Coyne, U Duvvuri, RL Ferris, ... Cancer 120 (23), 3627-3634, 2014 | 546 | 2014 |
| Interferon-γ drives Treg fragility to promote anti-tumor immunity AE Overacre-Delgoffe, M Chikina, RE Dadey, H Yano, EA Brunazzi, ... Cell 169 (6), 1130-1141. e11, 2017 | 538 | 2017 |
| The mutational landscape of adenoid cystic carcinoma AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ... Nature genetics 45 (7), 791-798, 2013 | 472 | 2013 |
| E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of … S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ... Journal of Clinical Oncology 35 (5), 490, 2017 | 463 | 2017 |
| Immune landscape of viral-and carcinogen-driven head and neck cancer AR Cillo, CHL Kürten, T Tabib, Z Qi, S Onkar, T Wang, A Liu, U Duvvuri, ... Immunity 52 (1), 183-199. e9, 2020 | 450 | 2020 |
| Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial FJ Civantos, RP Zitsch, DE Schuller, A Agrawal, RB Smith, R Nason, ... Journal of clinical oncology 28 (8), 1395, 2010 | 415 | 2010 |
| Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related … KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ... The Lancet Oncology 18 (8), 1104-1115, 2017 | 404 | 2017 |
| Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study DL Steward, SE Carty, RS Sippel, SP Yang, JA Sosa, JA Sipos, JJ Figge, ... JAMA oncology 5 (2), 204-212, 2019 | 403 | 2019 |
| Tumor antigen–targeted, monoclonal antibody–based immunotherapy: clinical response, cellular immunity, and immunoescape RL Ferris, EM Jaffee, S Ferrone Journal of Clinical Oncology 28 (28), 4390, 2010 | 398 | 2010 |
